1 active trials 1 recruiting 1 disease areas 2 changes in 30 days
| Phase 1/2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT06087653 | Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in… | Multiple Myeloma | Recruiting | 2026-08-24 |
Multiple Myeloma (1)